These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25062746)

  • 1. The free and cued selective reminding test distinguishes frontotemporal dementia from Alzheimer's disease.
    Lemos R; Duro D; Simões MR; Santana I
    Arch Clin Neuropsychol; 2014 Nov; 29(7):670-9. PubMed ID: 25062746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construct and diagnostic validities of the Free and Cued Selective Reminding Test in the Alzheimer's disease spectrum.
    Lemos R; Marôco J; Simões MR; Santana I
    J Clin Exp Neuropsychol; 2016 Oct; 38(8):913-24. PubMed ID: 27187087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free and cued selective reminding test predicts progression to Alzheimer's disease in people with mild cognitive impairment.
    Grande G; Vanacore N; Vetrano DL; Cova I; Rizzuto D; Mayer F; Maggiore L; Ghiretti R; Cucumo V; Mariani C; Cappa SF; Pomati S
    Neurol Sci; 2018 Nov; 39(11):1867-1875. PubMed ID: 30051200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social Cognition Deficits: The Key to Discriminate Behavioral Variant Frontotemporal Dementia from Alzheimer's Disease Regardless of Amnesia?
    Bertoux M; de Souza LC; O'Callaghan C; Greve A; Sarazin M; Dubois B; Hornberger M
    J Alzheimers Dis; 2016; 49(4):1065-74. PubMed ID: 26756325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The free and cued selective reminding test: Validation for mild cognitive impairment and Alzheimer's disease.
    Lemos R; Simões MR; Santiago B; Santana I
    J Neuropsychol; 2015 Sep; 9(2):242-57. PubMed ID: 24894485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free and Cued Selective Reminding Test is superior to the Wechsler Memory Scale in discriminating mild cognitive impairment from Alzheimer's disease.
    Lemos R; Cunha C; Marôco J; Afonso A; Simões MR; Santana I
    Geriatr Gerontol Int; 2015 Aug; 15(8):961-8. PubMed ID: 25243721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and Behavioral Profiles of Left and Right Semantic Dementia: Differential Diagnosis with Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
    Pozueta A; Lage C; García-Martínez M; Kazimierczak M; Bravo M; López-García S; Riancho J; González-Suarez A; Vázquez-Higuera JL; de Arcocha-Torres M; Banzo I; Jiménez-Bonilla J; Berciano J; Rodríguez-Rodríguez E; Sánchez-Juan P
    J Alzheimers Dis; 2019; 72(4):1129-1144. PubMed ID: 31683488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Episodic Memory Dysfunction in Behavioral Variant Frontotemporal Dementia: A Clinical And FDG-PET Study.
    Fernández-Matarrubia M; Matías-Guiu JA; Cabrera-Martín MN; Moreno-Ramos T; Valles-Salgado M; Carreras JL; Matías-Guiu J
    J Alzheimers Dis; 2017; 57(4):1251-1264. PubMed ID: 28304289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Reminding and Free and Cued Selective Reminding in Mild Cognitive Impairment and Alzheimer Disease.
    Lemos R; Afonso A; Martins C; Waters JH; Blanco FS; Simões MR; Santana I
    Appl Neuropsychol Adult; 2016; 23(2):85-93. PubMed ID: 26375308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort.
    Girtler N; Chincarini A; Brugnolo A; Doglione E; Orso B; Morbelli S; Massa F; Peira E; Biassoni E; Donniaquio A; Grisanti S; Pardini M; Arnaldi D; Nobili F
    J Alzheimers Dis; 2022; 87(2):887-899. PubMed ID: 35404273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of medial temporal impairment in degenerative dementia: a brain SPECT perfusion study in Alzheimer's disease and frontotemporal dementia.
    Basely M; Ceccaldi M; Boyer L; Mundler O; Guedj E
    Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):932-42. PubMed ID: 23553080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMA-93 Validation by Alzheimer's Disease Biomarkers: A Comparison with the Free and Cued Selective Reminding Test on a Biobank Sample.
    Rodrigo-Herrero S; Luque-Tirado A; Méndez-Barrio C; García-Solís D; Bernal Sánchez-Arjona M; Oropesa-Ruiz JM; Maillet D; Franco-Macías E
    J Alzheimers Dis; 2021; 82(1):401-410. PubMed ID: 34024831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The free and cued selective reminding test for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: A prospective longitudinal study.
    Lemos R; Marôco J; Simões MR; Santiago B; Tomás J; Santana I
    J Neuropsychol; 2017 Mar; 11(1):40-55. PubMed ID: 26058529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.
    Matias-Guiu JA; Cabrera-Martín MN; Curiel RE; Valles-Salgado M; Rognoni T; Moreno-Ramos T; Carreras JL; Loewenstein DA; Matías-Guiu J
    J Alzheimers Dis; 2018; 61(1):103-111. PubMed ID: 29125488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-stage differentiation between presenile Alzheimer's disease and frontotemporal dementia using arterial spin labeling MRI.
    Steketee RM; Bron EE; Meijboom R; Houston GC; Klein S; Mutsaerts HJ; Mendez Orellana CP; de Jong FJ; van Swieten JC; van der Lugt A; Smits M
    Eur Radiol; 2016 Jan; 26(1):244-53. PubMed ID: 26024845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of free and cued recall in Alzheimer's disease and vascular and frontotemporal dementia with 24-item Grober and Buschke test.
    Cerciello M; Isella V; Proserpi A; Papagno C
    Neurol Sci; 2017 Jan; 38(1):115-122. PubMed ID: 27672033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apathy in frontotemporal dementia and Alzheimer's disease: are there distinct profiles?].
    Derouesné C; Lacomblez L; Fiori N; Gély-Nargeot MC; Bungener C
    Geriatr Psychol Neuropsychiatr Vieil; 2012 Mar; 10(1):107-15. PubMed ID: 22414405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological Testing in Pathologically Verified Alzheimer Disease and Frontotemporal Dementia: How Well Do the Uniform Data Set Measures Differentiate Between Diseases?
    Ritter AR; Leger GC; Miller JB; Banks SJ
    Alzheimer Dis Assoc Disord; 2017; 31(3):187-191. PubMed ID: 28005562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer's Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
    Teng E; Manser PT; Shah M; Pickthorn K; Hu N; Djakovic S; Swendsen H; Blendstrup M; Faccin G; Ostrowitzki S; Sink KM
    J Prev Alzheimers Dis; 2023; 10(1):41-49. PubMed ID: 36641609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.